Trial NCT03915405

View at ClinicalTrials.gov 
Org. Study IDs: 2455-002
Secondary IDs: 2018-003796-35

Last trial update was posted on 2023-10-03

MeSH Interventions

Avelumab

MeSH Conditions

Carcinoma Carcinoma, Transitional Cell

Other Conditions

Urothelial Carcinoma

Stopping Reasons

Termination was based on the business decision

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID